Standard
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. / Ouaghlidi, A. El; Rehring, E.; Holst, J.J.; Schweizer, A.; Foley, J.; Holmes, D.; Nauck, M.A.
In:
Journal of Clinical Endocrinology and Metabolism, Vol. 92, No. 11, 2007, p. 4165-4171.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Ouaghlidi, AE, Rehring, E, Holst, JJ, Schweizer, A, Foley, J, Holmes, D & Nauck, MA 2007, 'The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion', Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4165-4171.
APA
Ouaghlidi, A. E., Rehring, E., Holst, J. J., Schweizer, A., Foley, J., Holmes, D., & Nauck, M. A. (2007). The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. Journal of Clinical Endocrinology and Metabolism, 92(11), 4165-4171.
Vancouver
Ouaghlidi AE, Rehring E, Holst JJ, Schweizer A, Foley J, Holmes D et al. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. Journal of Clinical Endocrinology and Metabolism. 2007;92(11):4165-4171.
Author
Ouaghlidi, A. El ; Rehring, E. ; Holst, J.J. ; Schweizer, A. ; Foley, J. ; Holmes, D. ; Nauck, M.A. / The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. In: Journal of Clinical Endocrinology and Metabolism. 2007 ; Vol. 92, No. 11. pp. 4165-4171.
Bibtex
@article{1851d61020ec11ddbc23000ea68e967b,
title = "The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion",
abstract = "Udgivelsesdato: 2007/11",
author = "Ouaghlidi, {A. El} and E. Rehring and J.J. Holst and A. Schweizer and J. Foley and D. Holmes and M.A. Nauck",
year = "2007",
language = "English",
volume = "92",
pages = "4165--4171",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "11",
}
RIS
TY - JOUR
T1 - The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion
AU - Ouaghlidi, A. El
AU - Rehring, E.
AU - Holst, J.J.
AU - Schweizer, A.
AU - Foley, J.
AU - Holmes, D.
AU - Nauck, M.A.
PY - 2007
Y1 - 2007
N2 - Udgivelsesdato: 2007/11
AB - Udgivelsesdato: 2007/11
M3 - Journal article
VL - 92
SP - 4165
EP - 4171
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 11
ER -
